Tag: FDA
-
Engineered T-Cell Trials Stopped after Patient Death
The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died.
-
Clinical Trial Okayed for Parkinson’s Drug Implant
A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease.
-
Study Testing Repurposed Drugs with Resistant Bacteria
A university team is investigating two current drug compounds for their ability to take on a new task, fighting bacteria becoming resistant to antibiotics.
-
Stem Cell Clinics Found Marketing in ClinicalTrials.gov
A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services.
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
Report: Long, Complex Effort Needed to Stem Opioid Abuse
A report released today says years of coordinated public health efforts are needed at all levels to contain and reverse the current opioid abuse epidemic.
-
Darpa Funding Research on Brain-Digital Implants
The advanced research agency in Department of Defense is supporting six new projects on neural devices that connect the brain to digital technologies to restore sensory functions.
-
FDA Approves Sickle Cell Drug
The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels.
-
Little Health Impact Found from Engineered Mosquitoes
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans.
-
Nerve Stimulation Approved for Children’s Epilepsy
The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old.